Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2012
12/04/2012CA2222509C Connective tissue growth factor
12/04/2012CA2210484C Composition to ameliorate osteolysis and metastasis
12/03/2012CA2742063A1 Method of obtaining a preparation of biological origin for oral hygiene to prevent the onset of tooth decay
11/2012
11/29/2012WO2012162637A2 Vaccine adjuvants from self-assembling peptides
11/29/2012WO2012162611A1 Simukunin
11/29/2012WO2012162565A2 Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions
11/29/2012WO2012162564A1 Method for inducing an immune response and formulations thereof
11/29/2012WO2012162555A2 Heparin nanoclusters
11/29/2012WO2012162547A2 Long duration dual hormone conjugates
11/29/2012WO2012162542A1 Amylin peptides and derivatives and uses thereof
11/29/2012WO2012162534A2 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
11/29/2012WO2012162490A1 Nanozyme compositions and methods of synthesis and use thereof
11/29/2012WO2012162392A1 Endothelium protective materials and methods of use
11/29/2012WO2012162342A2 Influenza vaccines containing modified adenovirus vectors
11/29/2012WO2012162253A2 Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
11/29/2012WO2012162215A1 Promotion of fracture healing using complement inhibitors
11/29/2012WO2012162179A1 Tau protease compositions and methods of use
11/29/2012WO2012162089A2 Sgef controls macular, corpus callosum and hippocampal function and development, liver homeostasis, functions of the immune system, fever response atherosclerosis and tumorogenic cell growth
11/29/2012WO2012161951A1 Peptides for preventing or treating a disease or disorder associated with cbp or p300 misregulation, and methods for use and identification thereof
11/29/2012WO2012161921A1 Intestinal hyperpermeability and prevention of systemic disease
11/29/2012WO2012161755A2 Antagonism of the vip signaling pathway
11/29/2012WO2012161746A1 Use of oxytocin or oxytocin analogues to treat obesity and diabetes
11/29/2012WO2012161545A2 Composition for promoting apoptosis or inhibiting cell growth, comprising epstein-barr virus microrna
11/29/2012WO2012161112A1 Novel metalloprotein and process for producing same, and prophylactic or therapeutic agent for corneal and conjunctival diseases comprising said metalloprotein
11/29/2012WO2012160990A1 Igf-1r-binding peptide
11/29/2012WO2012160563A2 Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
11/29/2012WO2012160485A1 Composition comprising interferon alpha
11/29/2012WO2012160333A2 Recombinant yeast
11/29/2012WO2012160215A1 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant
11/29/2012WO2012160213A1 Controlled release peptide formulations
11/29/2012WO2012160212A1 Peptide controlled-release formulations
11/29/2012WO2012160203A1 Mucosal delivery of drugs
11/29/2012WO2012159945A1 Ifn-beta compositions, preparation methods and uses thereof
11/29/2012WO2012159569A1 Application for prdx2 and/or prdx6 in preparation of pharmaceutical composition to treat or prevent damage, aging or disease resulting from increase of reactive oxygen species
11/29/2012WO2012159550A1 Fgfr-fc fusion protein and use thereof
11/29/2012WO2012159548A1 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
11/29/2012WO2012159263A1 Enzyme-degradable polymer and application thereof
11/29/2012WO2012159216A1 Bone tissue regenerating peptides
11/29/2012WO2012139099A3 Herpes simplex virus vaccine
11/29/2012WO2012139094A3 Method of developing a vaccine using peptide-poly ic complexes
11/29/2012WO2012138570A3 Modulating bacterial mam polypeptides in pathogenic disease
11/29/2012WO2012136909A3 Thixotropic α-lactalbumin hydrogels, method for preparing same and uses thereof
11/29/2012WO2012136224A3 Granulocyte -macrophage colony stimulating factor for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy
11/29/2012WO2012129513A3 Blockage of pai-1 in diabetic cd34+ stem cells corrects cellular dysfunction
11/29/2012WO2012116362A3 Chalcone derivatives as nrf2 activators
11/29/2012WO2012105813A3 Use of icam-1 for prevention or treatment of neurological diseases
11/29/2012WO2008045970A8 Compositions and methods of using chondroitinase abci mutants
11/29/2012US20120304321 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/29/2012US20120303083 Novel desmin phosphorylation sites useful in diagnosis and intervention of cardiac disease
11/29/2012US20120302816 Therapeutic compositions and methods for targeted delivery of active agents
11/29/2012US20120302739 Biological products
11/29/2012US20120302513 Mitochondrial Function Improver
11/29/2012US20120302512 Isolated laminin-421
11/29/2012US20120302511 Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer
11/29/2012US20120302510 Histone deacetylases, and uses related thereto
11/29/2012US20120302509 Compositions and methods to prevent cancer with cupredoxins
11/29/2012US20120302508 Sustained-release formulation
11/29/2012US20120302507 Liquid Product of Botulinum Toxin Type A
11/29/2012US20120302506 Maspin-based treatment and prevention of cancer
11/29/2012US20120302505 Cyclodextrin-based polymers for therapeutic delivery
11/29/2012US20120302504 Method Of Reducing Injury To Mammalian Cells
11/29/2012US20120302503 PEPTIDES FOR PREVENTING OR TREATING A DISEASE OR DISORDER ASSOCIATED WITH CBP OR p300 MISREGULATION, AND METHODS FOR USE AND IDENTIFICATION THEREOF
11/29/2012US20120302502 Mucosal delivery compositions comprising a peptide complexed with a crown compound and/or a counter ion
11/29/2012US20120302501 Treatment of diabetic cardiomyopathy with a glp-1 peptide
11/29/2012US20120302500 Use of somatostatin analogs in meningioma
11/29/2012US20120302499 Sterilized, acellular extracellular matrix compositions and methods of making thereof
11/29/2012US20120302498 Insulin like peptides
11/29/2012US20120302497 Methods of treating medical conditions using calcitonin analogs
11/29/2012US20120302496 Novel 24-membered cyclooctadepsipeptides from fungal strains and their use as anthelmintics or endoparasiticides
11/29/2012US20120302494 Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
11/29/2012US20120302493 Cyclic Peptides As G-Protein Coupled Receptor Antagonists
11/29/2012US20120302492 Antibody Mimetic Scaffolds
11/29/2012US20120302491 Modulation of estrogen receptor-related receptor gamma (err gamma) and uses therefor
11/29/2012US20120301552 CaSR Antagonist
11/29/2012US20120301546 Acid-resistant soft gel compositions
11/29/2012US20120301538 Pharmaceutical compositions for the stimulation of stem cells
11/29/2012US20120301535 Combination peptide-nanoparticles and delivery systems incorporating same
11/29/2012US20120301534 Method for lowering feed conversion rate
11/29/2012US20120301527 Hair follicle targeting compositions
11/29/2012US20120301518 Biocompatible and biodegradable elastomeric polymers
11/29/2012US20120301516 Particle- containing complex porous materials
11/29/2012US20120301514 Development of bioactive electrospun coatings for biomedical applications
11/29/2012US20120301508 Compositions for Induction of Osteogenesis around an Implant
11/29/2012US20120301499 Packaging of Immunostimulatory Substances into Virus-Like Particles: Method of Preparation and Use
11/29/2012US20120301491 Use of Modified Extracellular Matrix Proteins in Diagnosis and Treatment of Atherosclerosis
11/29/2012US20120301485 Juvenile Hemochromatosis Gene (HFE2A) Cleavage Products and Uses Thereof
11/29/2012US20120301482 Methods and compositions for treatment of lung injury
11/29/2012US20120301470 Use of tyrosine kinase inhibitors for treatment of cushing's disease and hypercortisolism
11/29/2012US20120301464 Janus kinase inhibitors for treatment of dry eye and other eye related diseases
11/29/2012US20120301458 Cyclopropyl modulators of p2y12 receptor
11/29/2012US20120301457 LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc
11/29/2012US20120301456 Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations
11/29/2012US20120301455 Botulinum toxin compositions
11/29/2012US20120301454 Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
11/29/2012US20120301453 Inhibiting integrin receptor binding with non-native monomeric disintegrin or monomeric disintegrin domains
11/29/2012US20120301446 Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders
11/29/2012US20120301441 Dextran-hyaluronic acid based hydrogels
11/29/2012US20120301439 Inhibition of choroidal neovascularization
11/29/2012US20120301436 Polyelectrolyte complex gels and soft tissue augmentation implants comprising the same
11/29/2012US20120301434 Antibacterial polypeptides and use thereof
1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 3163